|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.200 EUR | 0.00% |
|
-0.69% | -6.49% |
| 02-26 | EARNINGS AND TRADING: Connecting Excellence hails record January fees | AN |
| 02-26 | Malin Corporation says CEO Fiona Dunlevy will leave Malin end of May | RE |
| Market Cap | 31.21M 35.7M 28.79M 26.47M 50.15M 3.44B 51.01M 344M 135M 1.68B 134M 131M 5.79B | P/E 2024 * |
-
| P/E 2025 | -8.37x |
|---|---|---|---|---|---|
| Enterprise Value | 18.31M 20.95M 16.89M 15.53M 29.42M 2.02B 29.93M 202M 79.13M 985M 78.66M 76.94M 3.4B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
63.83% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | -0.69% | ||
| Current month | -3.36% | ||
| 1 month | -1.37% | ||
| 3 months | -13.25% | ||
| 6 months | -10.00% | ||
| Current year | -6.49% |
| 1 week | 7.2 |  | 7.25 |
| 1 month | 7.15 | | 7.45 |
| Current year | 7 | | 8.45 |
| 1 year | 7 | | 9.3 |
| 3 years | 3.84 | | 10.4 |
| 5 years | 3.59 | | 10.4 |
| 10 years | 1.4 | | 14.4 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrea Stafford
DFI | Director of Finance/CFO | 56 | 01/05/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
William Daniel
CHM | Chairman | 73 | 02/08/2019 |
| Director/Board Member | 67 | 16/07/2018 | |
Rudy Mareel
BRD | Director/Board Member | 63 | 16/07/2018 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-02 | Fiscal year | 10,307 | 0.2382% | |||
| 28/05/25 | Fiscal year | Chief Executive Officer | 5,746 | 0.1328% | ||
| 07/04/25 | Sell | Director | 11,075 | 0.2560% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | -0.69% | -10.56% | +50.63% | 35.72M | |
| -0.39% | -5.47% | +48.92% | +157.03% | 1,028B | |
| -2.32% | -5.31% | +60.73% | +56.79% | 611B | |
| +1.55% | -2.30% | +32.47% | +83.13% | 432B | |
| +0.98% | -1.40% | +29.49% | +23.12% | 323B | |
| -0.34% | -3.10% | +27.00% | +43.66% | 277B | |
| +1.63% | -11.76% | +19.72% | +23.20% | 257B | |
| +3.39% | +2.29% | -23.68% | -38.33% | 217B | |
| +0.86% | -2.70% | +22.40% | +57.15% | 192B | |
| +1.57% | -2.73% | +21.14% | +70.51% | 161B | |
| Average | +0.72% | -4.78% | +22.76% | +52.69% | 349.84B | |
| Weighted average by Cap. | +0.21% | -5.52% | +36.04% | +77.64% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | - | -6.9M -7.89M -6.37M -5.85M -11.09M -759M -11.28M -75.99M -29.82M -371M -29.64M -28.99M -1.28B |
| Net Debt | -62.1M -71.03M -57.29M -52.66M -99.78M -6.83B -101M -684M -268M -3.34B -267M -261M -11.51B | -12.9M -14.75M -11.9M -10.94M -20.73M -1.42B -21.08M -142M -55.74M -694M -55.41M -54.2M -2.39B |
Employees
2
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 15/07/26 | €7.200 | 0.00% | 0 |
| 14/07/26 | €7.200 | -0.69% | 70 |
| 13/07/26 | €7.250 | 0.00% | 0 |
| 10/07/26 | €7.250 | 0.00% | 0 |
| 09/07/26 | €7.250 | 0.00% | 268 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.200EUR
Average target price
15.50EUR
Spread / Average Target
+115.28%
- Stock Market
- Stocks
- MLC Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
